1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Mycophenolate: new trials by email Literature Review of Mycophenolate trials Research Report on Mycophenolate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) BIVV020 (SAR445088), Intravenous immunoglobulin (IVIg), Rituximab or biosimilar - Transplant Rejection | Phase 2 | Active not recruiting | Sanofi | 48 | 2022-06-09 | 2026-08-21 |
Sanofi (1)
Canada (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · Sweden (1) · United States (1)
2023 (1)